Author:
Kurbacheva O M,Nosulya E V,Kurbacheva O M,Nosulya E V
Reference70 articles.
1. Compalati E., Penagos M., Henley K., Canonica G.W. Allergy Prevalence Survey by the World Allergy Organization. Allergy Clin. Immunol. Int. J. World Allergy Org. 2007, v. 19, p. 82-90.
2. Asher M.I. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006, v. 368, p.733-743.
3. Prenner B.M., Schenkel E. Allergic rhinitis: treatment based on patient profiles. Am. J. Med. 2006, v. 119, p. 230-237.
4. van Drunen C., Meltzer E.O., Bachert C. et al. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate. Allergy. 2005, v. 60, p. S5-S19.
5. Bousquet J. Allergic rhinitis and its impact on asthma (ARIA). Clin. Exp. All. Rev. 2003, v. 3, p. 43-45.